Previous 10 | Next 10 |
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity through the 48 weeks of treatment Data presented today in a late-breaking ...
BOULDER, Colo., April 16, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debil...
BOULDER, Colo., April 15, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debil...
4 Penny Stocks to Watch as Stimulus Checks Roll In Markets were mixed at the open this morning, but it’s been a more bullish trend for penny stocks. In this case, let’s take a look at the Russell 2000 Small-Cap ETF ( NYSE: IWM ). As you’ll see, in tandem with ot...
Gainers: Neos Therapeutics (NEOS) +17%,Aytu BioScience (AYTU) +14%, Vericel (VCEL) +14%, Brickell Biotech (BBI) +14%, Infinity Pharmaceuticals (INFI) +13%.Losers: Translate Bio (TBIO) -32%, ContraFect (CFRX) -13%, Lipocine (LPCN...
BioHiTech Global (BHTG) +44% on receiving $2M in Digester orders.Upstart Holdings (UPST) +39% on Q4 results.Neos Therapeutics (NEOS) +30%.Seneca Biopharma (SNCA) +26%.Evolving Systems (EVOL) +24% on Q4 results.Can-Fite BioPharma (CANF) +17% on announcing new data from a pr...
The following slide deck was published by Brickell Biotech, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Brickell Biotech, Inc. 2020 Q4 - Results - Earnings Call Presentation
Brickell Biotech, Inc. (BBI) Q4 2020 Earnings Conference Call March 09, 2021, 04:30 PM ET Company Participants Dan Ferry - Investor Relations, LifeSci Advisors Robert Brown - Chief Executive Officer Deepak Chadha - Chief R&D Officer Bert Marchio - Chief Financial Officer Andy Sklawer - CO...
BOULDER, Colo., March 05, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today an...
ASLAN Pharmaceuticals Limited (ASLN) +71% as ASLAN004 shows positive effect in atopic dermatitis.Apollo Endosurgery (APEN) +47% after receiving a Breakthrough Device Designation from the USFDA for the Orbera® Intragastric Balloon.electroCore (ECOR) +39% on exclusive distri...
News, Short Squeeze, Breakout and More Instantly...
Brickell Biotech Inc. Company Name:
BBI Stock Symbol:
NYSE Market:
New name, logo, website, and branding reflect the Company’s strategic shift toward developing potentially groundbreaking autoimmune and inflammatory disease therapies Company to begin trading under new ticker symbol “FRTX” on September 8, 2022 Compan...
Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month On track to report SAD and MAD topline results from BBI-02 Phase 1 study by early 2023 Development of BBI-10 and next-generation kinase inhibitors advancing through early precl...
BOULDER, Colo., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoi...